Archives

Archive for January, 2012

extra, extra…

After The Risperdal Trial, J&J Looks More Like Humpty-Dumpty Forbes by Ed Silverman January 20, 2012 Now that Johnson & Johnson has agreed to pay $158 million to settle a lawsuit in which the Texas Attorney General charged the drugmaker with a whopper of a scheme to illegally promote its Risperdal antipsychotic, a couple of […]

selling psychiatry…

As strange as it might sound, all that testimony of the Janssen Sales Reps at last week’s Texas trial transported me directly back to the mid 1980s when we got a new chairman for our psychiatry department. He was a nice enough guy, but whenever I met with him, casually or officially, I left feeling […]

on every call…

  As I said, something about the testimony of the drug reps in the Texas Trial really pulled my chain. Interspersed in the Plaintiff’s testimony, we heard from some of Janssen’s Sales Reps and their  District Managers. The term Sales Reps replaced the former term, Detail Men, for several reasons. As Talbot noted in a […]

good·bye to all that…

My title is borrowed from a book by Robert Graves written in 1929. Graves is one of a group known as the British War Poets from World War I who set out to educate the English populace about the reality of war, and where they had sent their children. It’s pretty amazing how long it […]

not a half bad idea…

I haven’t known Allen Jones long and only recently met him in person [in Austin last week]. Until this morning, his lawyers had him on a tight leash – a very tight leash, and that has been true for years. In my practice, I saw a lot of people who had lived in adverse circumstances […]

opens the gate…

Fish & Richardson Attorneys Tom Melsheimer, Tommy Jacks Help Whistleblower, State of Texas Earn Historic Settlement in Lawsuit Over Risperdal Medication PRNewswire by Robert Tharp 01/19/2012 AUSTIN, Texas, Jan. 19, 2012 /PRNewswire/ — Lawyers for Texas Attorney General Greg Abbott and a Pennsylvania whistleblower have reached a $158 million settlement with a division of New […]

Allen’s pleased…

The settlement was $158 M. Lots of people are posting disappointment in that number, "cost of doing business." I just talked to Allen Jones and he didn’t sound one bit unhappy. He’s finally free from his 10 year black-out on being able to speak about the case publicly. And $158 M is a lot of […]

speaking of nails in the coffin…

Insider Trading, Goldman, Carlyle, Ally, TD in Court News Bloomberg By Elizabeth Amon January 19, 2012 … Johnson & Johnson [JNJ] officials hid three studies showing some patients using Risperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease, a witness testified. As early as 1999, Johnson & Johnson’s Janssen unit had researchers’ […]

a 1% market…

We saw the morning testimony in the Janssen trial in Austin, then drove to San Antonio and flew to Atlanta, then drove home to our cabin in North Georgia. Quite a week! Quite a Day! It was hard to leave Austin [I think trials might be addicting]. First up Tuesday morning was Toni Jones who […]

all too real…

Another blogger covering the trial has a pretty good profile of Allen Jones from last week [Lucre and the law: A money narrative of who stands to gain from suing a pharmaceutical company]. It’s ongoing coverage [see Risperdal on Trial]. I want to go back to the beginning of the day and start from scratch. […]